German federal Research Minister Jurgen Ruttgers has sharply criticized the attacks by opponents of genetic engineering and biotechnology on research units or sites earmarked for research in Germany. This year alone has seen 14 such attacks, and Mr Ruttgers says the attackers cannot be concerned with safety since many of the sites or units are involved in research on safety issues.
The Minister claims that despite supposed problems, Germany is actually experiencing a change of view in favor of biotechnology. A total of 13 proposals for genetech processes were submitted in 1995, and 29 applications have been filed so far in 1996. Mr Ruttgers said that after the revision of the genetic engineering law and the reshaping of genetic engineering safety regulations, there were no more barriers to biotech research and production, although there was a lack of capital.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze